Hopefully, Bill and Gill are on our case now speaking with some...

Hopefully, Bill and Gill are on our case now speaking with some of the big Pharma, ahead of the upcoming trials - looks like the share price is gaining some momentum as I write!

"Mark Diamond, CEO of Antisense Therapeutics said: “Our focus is to continue planning and to methodically and efficiently move our DMD program through Phase IIb in Europe. There is great interest in the DMD space. As we gain further certainty from the regulatory process on the parameters of the next trial, which may lead to early market approval, we will assess funding and trial management options and also engage in discussions with interested potential partners ahead of the commencement of Phase IIb. This will allow the Company to consider the most advantageous way to proceed with the pivotal trial on its own or with a partner. Potential partners’ input into the trial program may also be beneficial for future commercialization plans. The Company is now in the process of confirming the manufacture of additional clinical supplies of ATL1102 and will provide further updates in due course”.
https://www.antisense.com.au/wp-con...20_-21-May_-DMD-final-trial-results_FINAL.pdf
.